Does hand grip strength decrease in chronic obstructive pulmonary disease exacerbation? A cross-sectional study

Zeynep Turan, Özlem Özyemişçi Taşkıran, Zeynep Erden, Nurdan Köktürk, Gülçin Kaymak Karataş, Zeynep Turan, Özlem Özyemişçi Taşkıran, Zeynep Erden, Nurdan Köktürk, Gülçin Kaymak Karataş

Abstract

Background/aim: Respiratory and peripheral muscle strength are reduced in chronic obstructive pulmonary disease (COPD). There is a well-known correlation between handgrip strength (HGS) and strenght extremity muscles. Our aim in this study was to measure HGS and investigate the related factors in COPD patients with exacerbation.

Materials and methods: Subjects with COPD exacerbation (n = 101) and stable COPD (n = 22), and subjects without COPD (n = 201), were enrolled in this study. Age, sex, and body mass index were similar. HGS was measured using a Vigorimeter. Pulmonary function tests and 6-min walk tests were performed.

Results: The mean HGS was significantly lower in subjects with COPD exacerbation than those with stable COPD and subjects without COPD. The mean HGS was similar between stable COPD and non-COPD subjects. The mean 6-min walk distance (6MWD) was significantly lower in subjects with COPD exacerbation than stable COPD. There was a significant correlation between HGS and 6MWD but no correlation between HGS and pulmonary function tests.

Conclusion: In subjects with COPD exacerbation, the HGS was lower than that of stable COPD patients, and this difference was not explained by age, comorbidities, severity of obstruction, or smoking. Physical inactivity and steroid use during exacerbation might be possible factors affecting HGS. HGS was moderately correlated with 6MWD in cases of exacerbation. It may be used as a measure of muscle performance in COPD exacerbation, especially when the 6-min walk test cannot be performed.

Keywords: Chronic obstructive pulmonary disease; hand grip strength; 6-min walk distance; exacerbation; muscle strength.

Conflict of interest statement

CONFLICT OF INTEREST:

none declared

This work is licensed under a Creative Commons Attribution 4.0 International License.

Figures

Figure 1
Figure 1
Flow diagram of the study.

References

    1. Kim HC Mofarrahi M Hussain SN Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. International Journal of COPD. 2008;3:637.
    1. Franssen FM Broekhuizen R Janssen PP Wouters EF Schols AM Limb muscle dysfunction in COPD: effects of muscle wasting and exercise training. Med Sci Sports Exerc. 2005;37:2.
    1. Hamilton AL Killian KJ Summers E Jones NL Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med. 1995;152:2021.
    1. Zattara-Hartmann MC Badier M Guillot C Tomei C Jammes Y. Maximal force and endurance to fatigue of respiratory and skeletal muscles in chronic hypoxemic patients: the effects of oxygen breathing. Muscle Nerve. 1995;18:495.
    1. Bernard S LeBlanc P Whittom F Carrier G Jobin J Belleau R Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158:629.
    1. Rantanen T Volpato S Ferrucci L Heikkinen E Fried LP Guralnik JM Handgrip strength and cause-specific and total mortality in older disabled women: exploring the mechanism. J Am Geriatr Soc. 2003;51:636.
    1. Ling CH Taekema D de Craen AJ Gussekloo J Westendorp RG Maier AB Handgrip strength and mortality in the oldest old population: the Leiden 85-plus study. CMAJ. 2010;182:429.
    1. Gosselink R Troosters T Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med. 1996;153:976.
    1. Shah S Nahar P Vaidya S Salvi S. Upper limb muscle strength & endurance in chronic obstructive pulmonary disease. Indian J Med Res. 2013;138:492.
    1. Martinez CH Diaz AA Meldrum CA McDonald MLN Murray S Kinney GL Hokanson JE Curtis JL Bowler RP Han MK Handgrip strength in chronic obstructive pulmonary disease associations with acute exacerbations and body composition. Annals of the ATS. 2017;14:1638.
    1. Cortopassi F Divo M Pinto-Plata V Celli B Resting handgrip force and impaired cardiac function at rest and during exercise in COPD patients. Respir Med. 2011;105:748.
    1. Dourado VZ Antunes LC Tanni SE de Paiva SA Padovani CR Godoy I. Relationship of upper-limb and thoracic muscle strength to 6-min walk distance in COPD patients. Chest. 2006;129:551.
    1. Enright PL McBurnie MA Bittner V Tracy RP McNamara R Arnold A Newman AB The 6-min walk test: a quick measure of functional status in elderly adults. Chest. 2003;123:387.
    1. Gold PM The 2007 GOLD Guidelines: a comprehensive care framework. Respir Care. 2009;54:1040.
    1. Richards L Palmiter-Thomas P Grip strength measurement: a critical review of tools, methods, and clinical utility. Critical Reviews in Physical and Rehabilitation Medicine. 1996;8:1.
    1. Celli BR Macnee W Agusti A Berg B Buist AS Calverley PMA Chavannes N Dillars T Fahy B Fein A Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932.
    1. Holland AE Spruit MA Troosters T Puhan MA Pepin V Saey D McCormack MC Carlin BW Sciurba FC Pitta F An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44:1428.
    1. Vilaró J Ramirez-Sarmiento A Martínez-Llorens JM Mendoza T Alvarez M Sánchez-Cayado N Vega A Gimeno E Coronell C Gea J Global muscle dysfunction as a risk factor of readmission to hospital due to COPD exacerbations. Respir Med. 2010;104:1896.
    1. Heijdra YF Pinto-Plata V Frants R Rassulo J Kenney L Celli BR Muscle strength and exercise kinetics in COPD patients with a normal fat-free mass index are comparable to control subjects. Chest. 2003;124:75.
    1. Ansari K Keaney N Taylor I Burns G Farrow M. Muscle weakness, health status and frequency of exacerbations in chronic obstructive pulmonary disease. Postgrad Med J. 2012;88:372.
    1. Gea J Agustí A Roca J Pathophysiology of muscle dysfunction in COPD. J Appl Physiol. 2013;114:1222.
    1. Mador MJ Bozkanat E. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Respir Res. 2001;2:216.
    1. Wouters EF Muscle wasting in chronic obstructive pulmonary disease: to bother and to measure! Am J Respir Crit Care Med. 2006;173:4.
    1. Rantanen T Guralnik JM Sakari-Rantala R Leveille S Simonsick EM Ling S Fried LP Disability, physical activity, and muscle strength in older women: the Women’s Health and Aging Study. Arch Phys Med Rehabil. 1999;80:130.
    1. Kaymaz D Candemir İÇ Ergün P Demir N Taşdemir F Relation between upper-limb muscle strength with exercise capacity, quality of life and dyspnea in patients with severe chronic obstructive pulmonary disease. Clin Respir J. 2018;12:1257.
    1. Sayer AA Syddall HE Martin HJ Dennison EM Roberts HC Cooper C Is grip strength associated with health-related quality of life? Findings from the Hertfordshire Cohort Study. Age Ageing. 2006;35:409.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe